SCHEMBL31153449

SCHEMBL31153449

FC(F)c1cc2c(cc1Cl)CCCN2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ GAA P10253 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TP53 P04637 2/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ AR P10275 2/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ ATM Q13315 1/20 0.35
▸ PYGL P06737 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17785725 0.80 MAPT (0.40) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL11015073 0.80 MAPT (0.44) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL10913742 0.77 KDM4E (0.41) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL30888682 0.77 KDM4E (0.41) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL4779518 0.74 HTR2A (0.41) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL10911503 0.74 ATM (0.48) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL30888660 0.74 HTR2A (0.41) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL10911885 0.73 AR (0.52) KDM4EMAPTGAAALDH1A1TP53
SCHEMBL31153456 0.72 ALDH1A1 (0.42) KDM4EMAPTGAAALDH1A1HSD17B10
SCHEMBL23930147 0.72 MAPT (0.35) KDM4EMAPTGAAALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698544-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2026-02-25 — — EP disclosed
WO-2024220946-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-10-24 — — WO disclosed
Send feedback